Investing Profile

Eric Anschutz

AngelInvestorScoutFounder

Experienced angel with biotech focus. Selective deal flow supported by quantitative evaluation system. Proven, exit-driven results over 15+ years. Bike lover.

angel.co/s/anschutz/2oq0tSan Francisco, California
Photo of Eric Anschutz

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$10K - $250K
$25K
31
CompanyStageDateRound SizeTotal Raised
Attivare Therapeutics
SeedJun 2021$1
$5M
Co-investors: Maximilian Winter (Harmonix Fund)
Primordial Genetics
Seed RoundFeb 2021$1
$1
HDT Bio
Seed RoundFeb 2021$6M
Seed RoundOct 2020$6M
$12M
SMBX
Seed RoundAug 2020$2.5M
$5M
Co-investors: Wes Selke (Better Ventures), Jordan Fliegel (Techstars)
OccamzRazor
Seed RoundMay 2019$4.5M
Seed RoundFeb 2017
$4.5M
Co-investors: Phil Libin (General Catalyst), Nate Dalton (Daybreak Partners), Justin Rosenstein
MycoWorks
Venture RoundOct 2018
SeedMar 2018$1
$45M
Co-investors: Tony Fadell (Future Shape), Arvind Gupta (SOSV), Seth Berman (Susa Ventures), Po Bronson (SOSV)
Notable Labs
Series BSep 2017$15M
$76M
Co-investors: John Kim (AMASIA), Ramanan Raghavendran (AMASIA), Milad Alucozai (BoxOne Ventures), John Noonan (Lifeforce Capital), Chris Sklarin (Alumni Ventures Group), Anton Simunovic (Alumni Ventures Group), Charlie Pinto (Bling Capital), Stefano Bernardi (Atomico), Ross Blankenship (Angel Kings), Kevin Mahaffey (SNR), Jim Kim (formation|8)
Twist Bioscience
Series DMar 2017$33M
Series DJan 2016$61M
$170M
Co-investors: Omri Amirav Drory (NFX), Eric Moessinger (NanoDimension), Paul Conley (Paladin Capital Group), Nick Naclerio (Illumina Ventures), Gibb Witham (Paladin Capital Group), Boris Nikolic (Biomatics Capital Partners), rich simoni
Biotech, Synthetic Biology, Bicycles, Medical Bioinformatics, Genomics, Genetic Testing, Biotechnology, DNA/RNA, Microbiome, Quantified Self, Medical Devices, Internet of Things, Pharmaceuticals, Bio-Pharma